RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells

Background Originally identified for its involvement in bone remodeling, accumulating data emerged in the past years indicating that receptor activator of nuclear factor κB ligand (RANKL) actually acts as a multifunctional soluble molecule that influences various physiological and pathological proce...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pascale Hubert, Patrick Roncarati, Charlotte Pilard, Marie Ancion, Celia Reynders, Thomas Lerho, Diane Bruyere, Alizee Lebeau, Marie-Julie Nokin, Elodie Hendrick, Olivier Peulen, Philippe Delvenne, Michael Herfs, Margaux Luyckx, Michael Renard, Florian Poulain, Rebekah Crake, Raphael Peiffer
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-03-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/13/3/e010753.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Correction: Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer
by: Marie-Julie Nokin, et al.
Published: (2025-06-01)

Metabolism Is Central to Tolerogenic Dendritic Cell Function
by: Wen Jing Sim, et al.
Published: (2016-01-01)

Administration of RANKL boosts thymic regeneration upon bone marrow transplantation
by: Noella Lopes, et al.
Published: (2017-04-01)

MicroRNA Profiling of Activated and Tolerogenic Human Dendritic Cells
by: Zuzana Stumpfova, et al.
Published: (2014-01-01)

Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis
by: Zhong-Xiang Xie, et al.
Published: (2015-01-01)

A comprehensive overview of tolerogenic vaccine adjuvants and their modes of action
by: Sabine Arve-Butler, et al.
Published: (2024-12-01)

The ADAMTS2 metalloproteinase inhibits tumor growth by regulating the innate immune system
by: Loïc Joannes, et al.
Published: (2025-06-01)

Nodal Mature Plasmacytoid Dendritic Cell Proliferation in a Patient With Chronic Myelomonocytic Leukemia: A Diagnostic Mimic of Blastic Plasmacytoid Dendritic Cell Neoplasm
by: Jowan Al-Nusair MD, et al.
Published: (2025-05-01)

Ultraviolet Radiation-Induced Tolerogenic Dendritic Cells in Skin: Insights and Mechanisms
by: Gelare Ghajar-Rahimi, et al.
Published: (2025-02-01)

Molecular Mechanisms of Induction of Tolerant and Tolerogenic Intestinal Dendritic Cells in Mice
by: Alex Steimle, et al.
Published: (2016-01-01)

Tolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal Blockage
by: Priscila de Matos Silva, et al.
Published: (2015-01-01)

Rectal Stricture Caused by a Rare Plasmacytoid Urothelial Carcinoma
by: Ahmad Alnasarat, et al.
Published: (2024-01-01)

Impaired interferon‐α expression in plasmacytoid dendritic cells in asthma
by: Ting‐Yu Lin, et al.
Published: (2021-03-01)

Neisseria gonorrhoeae Induces a Tolerogenic Phenotype in Macrophages to Modulate Host Immunity
by: Alejandro Escobar, et al.
Published: (2013-01-01)

Clinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative Effort
by: Anja Ten Brinke, et al.
Published: (2015-01-01)

Physiological Role of Plasmacytoid Dendritic Cells and Their Potential Use in Cancer Immunity
by: Pinku Mukherjee, et al.
Published: (2008-01-01)

Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report
by: Jasper X Zheng, et al.
Published: (2024-12-01)

Therapeutic Potential of Tolerogenic Dendritic Cells in IBD: From Animal Models to Clinical Application
by: Raquel Cabezón, et al.
Published: (2013-01-01)

Role of USP7 in the regulation of tolerogenic dendritic cell function in type 1 diabetes
by: Farhan Ullah Khan, et al.
Published: (2025-04-01)

Fluoxetine inhibited RANKL-induced osteoclastic differentiation in vitro
by: Zhang Jing-wen, et al.
Published: (2024-12-01)

An Unusual Manifestation of Blastic Plasmacytoid Dendritic Cell Neoplasm as a Testicular Tumor
by: Daniel M. Pak, et al.
Published: (2019-01-01)

Plasmacytoid dendritic cells and their role in the immunopathogenesis of viral infections for example hepatitis B
by: R. R. Khodzhibekov, et al.
Published: (2019-05-01)

Blastic plasmacytoid dendritic cell neoplasm in a young female: Rare and challenging
by: Ketan Modak, et al.
Published: (2020-01-01)

Unfolding anti-tumor immunity: ER stress responses sculpt tolerogenic myeloid cells in cancer
by: Eslam Mohamed, et al.
Published: (2017-08-01)

Tapinarof inhibits psoriatic inflammation through inducing tolerogenic dendritic cells and Foxp3+ Tregs
by: Yan Zhao, et al.
Published: (2024-12-01)

THE ROLE OF OSTEOPROTEGERIN SYSTEM /RANKL/RANK IN PATHOGENESIS OF AORTIC STENOSIS
by: O. B. Irtyuga, et al.
Published: (2018-03-01)

Anti-RANKL Inhibits Thymic Function and Causes DRONJ in Mice
by: Yusuke Nakamura, et al.
Published: (2022-01-01)

The effect of vitamin D deficiency on the RANKL/OPG ratio in rats
by: Rawan M. Khalaf, et al.
Published: (2022-03-01)

HIV Modulates Osteoblast Differentiation via Upregulation of RANKL and Vitronectin
by: Rosa Nicole Freiberger, et al.
Published: (2024-09-01)

Plasmacytoid dendritic cells sequester high prion titres at early stages of prion infection.
by: Rocio Castro-Seoane, et al.
Published: (2012-02-01)

Management of blastic plasmacytoid dendritic cell neoplasm: a case series from Chile
by: Maximiliano Vergara, et al.
Published: (2025-03-01)

Blastic Plasmacytoid Dendritic Cell Neoplasm Mimicking Erythema Nodosum: A Case Report
by: Marino Hirata, et al.
Published: (2023-02-01)

Promoting ER stress in a plasmacytoid dendritic cell line drives fibroblast activation
by: Beatriz H. Ferreira, et al.
Published: (2025-02-01)

Adoptive Cell Therapy of Induced Regulatory T Cells Expanded by Tolerogenic Dendritic Cells on Murine Autoimmune Arthritis
by: Jie Yang, et al.
Published: (2017-01-01)

Tolerogenic versus Inflammatory Activity of Peripheral Blood Monocytes and Dendritic Cells Subpopulations in Systemic Lupus Erythematosus
by: Tiago Carvalheiro, et al.
Published: (2012-01-01)

Effect of fungal microbiota on RANKL and sclerostin in patients with Crohn's disease
by: Rana Hanan Al-rubaye, et al.
Published: (2025-03-01)

Assessment of Salivary Levels of RANKL and OPG in Aggressive versus Chronic Periodontitis
by: Alexandra Cornelia Teodorescu, et al.
Published: (2019-01-01)

Associations of RANKL levels and polymorphisms with rheumatoid arthritis: A meta-analysis.
by: Young Ho Lee, et al.
Published: (2025-01-01)

Inhibition of choroidal osteoma progression using bisphosphonate and RANKL-inhibitory treatment
by: Mélanie Hébert, et al.
Published: (2024-12-01)

A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Extensively Studied by Flow Cytometry and Immunohistochemistry
by: Martina Pennisi, et al.
Published: (2017-01-01)